Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · IEX Real-Time Price · USD
1.200
+0.020 (1.69%)
At close: Jul 26, 2024, 2:34 PM
1.180
-0.020 (-1.67%)
After-hours: Jul 26, 2024, 4:00 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $5.36 million as of July 26, 2024. Its market cap has decreased by -44.20% in one year.
Market Cap
5.36M
Enterprise Value
1.07M
1-Year Change
-44.20%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since November 8, 2021, Bright Minds Biosciences's market cap has decreased from $97.80M to $5.36M, a decrease of -94.52%. That is a compound annual growth rate of -65.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 5.40M | -15.63% |
| Dec 29, 2023 | 6.40M | -50.77% |
| Dec 30, 2022 | 13.00M | -65.33% |
| Dec 31, 2021 | 37.50M | -61.66% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 5.80M |
| Oragenics | 5.80M |
| FSD Pharma | 5.74M |
| Biofrontera | 5.50M |
| Titan Pharmaceuticals | 5.47M |
| Lixte Biotechnology Holdings | 5.37M |
| ENDRA Life Sciences | 5.36M |
| Hoth Therapeutics | 5.33M |